Home›Stock Screener›Brawn Biotech

Brawn Biotech Share Price Today | Stock Price & Brawn Biotech Share Screener

BRAWN Pharmaceuticals
Live Share Price BSE
₹24.50
▼ -0.10 (-0.41%)
2026-10-05 00:00:00

As of October 5, 2026, the live Brawn Biotech share price (BSE: BRAWN) is ₹24.50, down 0.41% from the previous close, with shares trading between ₹23.37 and ₹24.65 in today's trading session, and a 52-week range of ₹17.85–₹24.60. Check BRAWN yearly price range for the annual price range and momentum. Use the Brawn Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Brawn Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Brawn Biotech Market Cap ₹7.03 Cr.
BRAWN P/E Ratio (TTM) 31.40
Brawn Biotech P/B Ratio 2.46
EPS (TTM) ₹3.26
Dividend Yield -
Debt to Equity -
BRAWN 52 Week High ₹24.60
Brawn Biotech 52 Week Low ₹17.85
Operating Margin -33.00%
Profit Margin -
BRAWN Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹21.00
Total Equity ₹4.00

Brawn Biotech Share Price Chart

Track the current stock price of Brawn Biotech with an interactive chart. Analyse BRAWN share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Brawn Biotech stock quote in one place.

The quote of ₹24.50 sits between the 52-week low of ₹17.85 and the 52-week high of ₹24.60, and the latest session moved -0.41% from the previous close.

Brawn Biotech Company Profile - Fundamental Screener

Screen Brawn Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BRAWN shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE899B01015.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE899B01015

Brawn Biotech Balance Sheet Screener

Screen BRAWN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹21, down from ₹21 in 2025.

Latest statistics put total assets at ₹21 and shareholder funds at ₹4.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 21 21 15 15 14 14 20 23 23 17
Current Assets 17 18 13 13 12 13 19 22 22 17
Fixed Assets 0 1 0 0 0 0 0 0 0 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 8 3 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 4 3 5 6 7 9 9 9 8 7
Share Capital 3 3 3 3 3 3 3 3 3 3
Reserves & Surplus 1 0 2 3 4 6 6 6 5 4

Brawn Biotech Income Statement Screener - Profit & Revenue Analysis

Screen Brawn Biotech income statement and profit fundamentals. Analyze BRAWN quarterly results. Brawn Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2023-Jun, revenue was ₹0 and net profit was ₹0, equal to earnings per unit of ₹-0.08, at an operating margin of -33%.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2023-Mar, shows revenue of ₹0 and net profit of ₹0.

Item 2023-Jun 2023-Mar 2022-Jun

Revenue and Expenses

Revenue 0 0 0
Expenses 0 0 0

Operating Costs and Margins

EBITDA 0 0 0
Operating Profit % -33.00% 25.00% 25.00%
Depreciation 0 0 0
Interest 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0
Tax 0 0 0
Net Profit 0 0 0
EPS -0.08 0.47 0.05

Brawn Biotech Cash Flow Screener - Liquidity Fundamentals

Screen BRAWN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1, and net cash flow was an inflow of ₹1.

Over the same period, investing activities provided ₹0 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 1 0 0 0 0 0 0 0 -2 1
Investing Activities 0 0 0 0 0 0 0 0 0 1

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 1 0 0 0 0 0 0 0 -2 2

Brawn Biotech Shareholding Pattern Screener

See Brawn Biotech shareholding pattern with promoter, FII, and DII holdings. Check Brawn Biotech promoter holding and ownership changes for BRAWN on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 52.94%, foreign institutions 0.00%, domestic institutions 0.35% and the public 30.49%, spread across 3,303 shareholders.

The shareholder count was 3,303 in 2026-Mar, compared with 3,284 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 52.94% 52.94% 53.66% 53.66% 53.66% 53.39% 53.64% 53.64%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35% 0.35%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 30.49% 30.53% 33.17% 32.88% 32.90% 30.97% 33.91% 33.96%
Other Holding 16.22% 16.18% 12.82% 13.11% 13.09% 15.29% 12.10% 12.05%
Shareholder Count 3,303 3,284 4,024 3,975 3,958 3,444 4,160 4,090

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Brawn Biotech. Brawn Biotech dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹1.00 2.69%
2017-March ₹1.50 2.79%

Brawn Biotech Stock Index Membership - Nifty & Sensex

See which indices include Brawn Biotech stock. Check BRAWN index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Brawn Biotech is not part of any tracked indices.
Only major market indices are tracked in our system.

Brawn Biotech Market Events Screener - Corporate Actions

Get Brawn Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Brawn Biotech stock events that may affect BRAWN share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 29, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-29 2026-09-29 Annual General Meeting NA 5.37%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -7.69%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -6.81%
2026-02-14 2026-02-14 Quarterly Result Announcement NA -3.48%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 9.95%
2025-09-30 2025-09-30 Annual General Meeting NA -13.35%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -16.28%
2025-05-26 2025-05-26 Quarterly Result Announcement NA 1.04%
2025-02-12 2025-02-12 Quarterly Result Announcement NA 25.30%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -1.44%
2024-09-30 2024-09-30 Annual General Meeting NA 0.10%

Brawn Biotech Competitors Screener - Peer Stocks Comparison

Screen BRAWN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 430,969 35.84 61,674 12.69% 11,565 36.68
Divis Laboratories 242,638 84.36 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 179,564 84.01 13,886 20.34% 2,138 41.12
Zydus Life Science 113,017 24.88 27,658 17.64% 5,026 47.64
Cipla 107,599 32.42 29,045 2.24% 3,870 34.78
Laurus Labs 106,512 98.56 6,868 22.01% 890 58.70
Mankind Pharma 103,939 50.48 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,145 31.47 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,232 25.97 34,145 5.56% 3,503 50.30
Lupin 91,993 16.71 29,039 26.75% 5,356 31.59

Brawn Biotech Company Announcements - News & Reports Screener

Screen BRAWN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 1, 2026.

The next most recent announcements are dated October 1, 2026 and October 1, 2026.

Date Update Actions
2026-10-01 Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-10-01 Proceedings Of 41St AGM -
2026-10-01 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-29 Closure of Trading Window -
2026-09-02 Intimation W.R.T Letter Sent To Shareholders As Per Reg 36 -
2026-09-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-01 Reg. 34 (1) Annual Report. -
2026-09-01 Notice Of 41St AGM To Be Held On 29.09.2026 -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Outcome Of Board Meeting Held On August 13 2026 To Consider And Approve Inter-Alia Un-Audited Financial Results Of The Company For Quarter Ended June 30 2026. -
2026-08-13 Board Meeting Outcome for Outcome Of Board Meeting Held On August 13 2026 To Consider And Approve Inter-Alia Un-Audited Financial Results Of The Company For Quarter Ended June 30 2026. -
2026-08-05 Board Meeting Intimation for Consideration And Approval Of Inter Alia The Un-Audited Financial Results Of The Company For The Quarter Ended June 30 2026. -
2026-07-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -
2026-05-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-30 Intimation Regarding Non-Applicability Of Regulation 23(9) -
2026-05-30 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-29 Results- Financial Results For Year Ended 31St March 2026 -
2026-05-29 Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 29Th May 2026 And Submissions Of Audited Financial Results For The Quarter And Year Ended 31.03.2026 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹24.50, within a 52-week range of ₹17.85 to ₹24.60. The P/E ratio is 31.40 and the P/B ratio is 2.46, with earnings per unit of ₹3.26. Market capitalisation stands at ₹7.03 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 3 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.